Treatment of cultured breast cancer cells with indole-3-carbinol induced cell cycle arrest and disrupted combined estrogen receptor-alpha and Sp1-driven transcription of the hTERT gene [340]. This evidence concerns the gene ESR1 and breast carcinoma.